2-Methylpyridine-3,4-diamine

Catalog No. :
ACHVGC056
CAS No. :
15931-19-8
Molecular Formula :
C6H9N3
Molecular Weight :
123.16

IUPAC Name:2-methylpyridine-3,4-diamine

2-Methylpyridine-3,4-diamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$77.00Login to see priceIn stockIn stock
1g95%$234.00Login to see priceIn stockIn stock
5g95%$707.00Login to see priceIn stockInquiry
25g95%$3064.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Methylpyridine-3,4-diamine
IUPAC Name2-methylpyridine-3,4-diamine
MDL No.MFCD10000599
Molecular FormulaC6H9N3
Molecular Weight123.16
SMILESCC1=NC=CC(N)=C1N
InChI KeyCXCMHIHWZCWXQU-UHFFFAOYSA-N
Synonym2-methylpyridine-3,4-diamine | 15931-19-8 | 3,4-Diamino-2-methylpyridine | 3,4-PYRIDINEDIAMINE, 2-METHYL- | 3,4-Pyridinediamine,2-methyl- | 3,4-Diamino-2-picoline | SCHEMBL373587 | DTXSID10597956 | CXCMHIHWZCWXQU-UHFFFAOYSA-N | MFCD10000599 | AKOS006304748 | AB55860 | CS-W021728
CAS No.15931-19-8
PubChem CID19088666

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACHVGC056 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFWNO746 route compound structure diagram
    ACFWNO74627582-14-5 In Stock
  2. Then
  3. ACHVGC056 route product structure diagram
    ACHVGC05615931-19-8 In Stock
Inquiry

2. ACHVGC056 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACFWNO746 route compound structure diagram
    ACFWNO74627582-14-5 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACHVGC056 route product structure diagram
    ACHVGC05615931-19-8 In Stock
Inquiry

Comments (0)